aTyr Pharma (ATYR)

• Market cap: $47.1M
• 1 day: -0.62%
• 5 days: -4%
• 1 month: -19.57%
• 3 months: -40.55%
• 6 months: -45.63%
• Year to date: -36.77%
• 1 year: -90.28%
• 5 years: -89.7%
• 10 years: -98.92%
• Sector: Healthcare
• Industry: Biotechnology

About: aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Employees: 58